NT-506-ECT

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameNT-506-ECT
Drug Alias NameNT-506NT-506-ECT
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor antagonists
TargetsPlatelet-derived growth factor receptorVascular endothelial growth factor receptor
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsWet age-related macular degeneration

Other Information

ATC CodeN/A
Related LinksN/A